Patent holdings for IPC class A61K 38/48

Total number of patents in this class: 3879

10-year publication summary

361
350
395
402
351
392
338
332
279
23
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Allergan, Inc.
2438
156
Talengen International Limited
87
65
Ipsen Biopharm Limited
268
64
MERZ PHARMA GmbH & CO. KGaA
612
62
Baxter International Inc.
2459
37
The Regents of the University of California
19517
36
Curemark, LLC
78
36
Revance Therapeutics, Inc.
153
34
Bioverativ Therapeutics Inc.
213
33
Takeda Pharmaceutical Company Limited
2943
31
The Children's Hospital of Philadelphia
752
31
Modernatx, Inc.
1206
31
Translate bio, Inc.
413
30
Baxter Healthcare S.A.
1850
29
HANSA Biopharma AB
70
29
Penland Foundation
38
29
Omrix Biopharmaceuticals Ltd.
155
28
Talengen Institute of Life Sciences Co., Ltd.
28
25
Alexion Pharmaceuticals, Inc.
622
24
Smith & Nephew, Inc.
2681
24
Other owners 3045